Nureca Limited has informed the exchange regarding the re-appointment of Mr. Aryan Goyal as Whole-time Director & CEO of the company for a period of three years with effect from May 28, 2027.
NURECA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Nureca Limited held a board meeting on May 29, 2026 approving multiple items. Financially, the company reported FY26 standalone revenue of Rs 1,472.10 million (up 28% from Rs 1,146.40 million in FY25) with a net profit after tax of Rs 2.97 million versus a loss of Rs 6.68 million in FY25. However, Q4 FY26 showed a loss of Rs 66.25 million due to a Rs 83.37 million fair value loss on investments. Key management changes include the resignation of CFO Mr. Naresh Gupta (effective June 26, 2026) who left for better career opportunities, with Mr. Chander Kant promoted internally as new CFO effective June 27, 2026. The board also approved re-appointment of Mr. Aryan Goyal as Whole-time Director & CEO (from May 28, 2027) and Mr. Saurabh Goyal as Managing Director (from September 3, 2026), and appointed Ms. Smita Goyal as Additional Whole-time Director (from June 1, 2026) — all subject to shareholder approval. Additionally, the board approved Rs 100 crore capex for manufacturing expansion and land purchase at Derabassi, Punjab.
Mixed signals — return to profitability and expansion plans are positive, but CFO resignation followed by immediate replacement suggests management transition risk. The concentration of key roles with family members (Aryan, Saurabh, and Smita Goyal are siblings/in-laws) raises governance concerns for minority shareholders.